Morgia, Marilyn .
HRN: 26-66-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/22/2025
03/24/2025
IV
500mg
Q8hrs X 6 Doses
S/P Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes